News

Skyphos to Showcase Additive Lithography at the Microfluidics Consortium Open Day in Boston

Skyphos Technologies, a Virginia Tech Corporate Research Center company advancing micro-scale and additive lithography manufacturing, will participate in the Microfluidics Consortium Open Day Meeting in Boston, where the company has been invited to present in the Physical Microfluidics Hotseat and deliver a tabletop demonstration.

The Microfluidics Consortium convenes worldwide leaders, from research and industry, bringing together stakeholders from materials, device development, instrumentation, and applications to accelerate adoption of microfluidics-enabled products and services. The Boston meeting is part of the consortium’s international event series and is organized around expert talks, startup hot-seat pitches, live demonstrations, and face-to-face networking.

At the event, Skyphos will highlight its advanced micro-fabrication platform and vertically integrated approach, aimed at enabling scalable, high-precision production of microdevice architectures outside of the clean room at scale. Skyphos specializes in components and process development relevant to lab-on-a-chip systems and related applications.

Participation in the Physical Microfluidics Hot-Seat places Skyphos alongside emerging companies and thought leaders presenting new approaches in the fields of diagnostics, therapeutics, organ-on-chip, synthetic biology, and next-generation microfluidic systems. The consortium’s broader mission is to connect participants from across Europe, the United States, and Asia to help move promising microfluidics technologies from concept toward commercial use.

“Skyphos is building manufacturing infrastructure for the next generation of microfluidic devices,” said Elliot McAllister- Founder. “This invitation to Boston reflects a growing recognition that scalable microfabrication remains a key bottleneck to the field. Skyphos and others are showing that new manufacturing models can translate and grow strong techniques and applications. Getting cures from lab to fab.”

Located within the Virginia Tech Corporate Research Center community, Skyphos represents the kind of deep-tech company the CRC was built to support: a venture combining advanced engineering, research-driven innovation, and commercial ambition. The company’s participation in Boston underscores the reach of Virginia-based innovation in emerging sectors where manufacturing and life sciences intersect.

 

Recent News

05/18/2026

Skyphos to Showcase Additive Lithography at the Microfluidics Consortium Open Day in Boston

Skyphos Technologies, a Virginia Tech Corporate Research Center company advancing micro-scale and additive lithography manufacturing, will participate in the Microfluidics Consortium Open Day Meeting in Boston, where the company has been invited to present in the Physical Microfluidics Hotseat and deliver a tabletop demonstration. The Microfluidics Consortium convenes worldwide leaders, from research and industry, bringing

05/18/2026

Neurocrine Biosciences Completes Acquisition of Soleno Therapeutics

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced the completion of its acquisition of Soleno Therapeutics, Inc., strengthening the company’s leadership in endocrinology and rare disease. The acquisition adds VYKAT™ XR (diazoxide choline) tablets, the first and only approved medicine for hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome, to

05/15/2026

OsteoStrong Expands in Virginia with New Location in Tysons, Virginia

OsteoStrong, a global leader in skeletal strength conditioning, is expanding in Northern Virginia with a new location in Tysons, Virginia, offering residents a cutting-edge, drug-free solution to improve bone density, strength and overall skeletal health in just 10-minute sessions per week. Located at 8609 Westwood Center Drive, Suite 625, Vienna, VA 22182, OsteoStrong Tysons VA